Undecaprenyl pyrophosphate phosphatase confers low-level resistance to bacitracin in Enterococcus faecalis

J Antimicrob Chemother. 2013 Jul;68(7):1583-93. doi: 10.1093/jac/dkt048. Epub 2013 Mar 3.

Abstract

Objectives: Undecaprenyl pyrophosphate phosphatases (UppPs) have been implicated in bacitracin resistance in some bacterial genera and the aim of this study was to determine the role of UppPs in mediating low-level bacitracin resistance in Enterococcus faecalis.

Methods: The uppP gene was identified in the genomes of laboratory (JH2-2) and clinical (V583) strains of E. faecalis. Gene fusions (uppP-lacZ) and 5'-RACE were used to study uppP expression. The uppP gene in both strains was inactivated and mutants were studied for antimicrobial susceptibility and their susceptibilities to various stress agents.

Results: The UppP protein from E. faecalis showed high sequence identity to the Escherichia coli BacA-type UppP and was predicted to be a hydrophobic protein with eight transmembrane helices. The expression of uppP-lacZ was constitutive and not affected by bacitracin or cell wall-active antimicrobials. E. faecalis uppP mutants showed no significant changes in growth rate, colony morphology and biofilm formation. The uppP mutants exhibited increased susceptibility to bacitracin (MICs=3-6 mg/L) relative to the isogenic wild-type (MICs=32-48 mg/L). When uppP was expressed in a wild-type background, the MIC of bacitracin increased to 128-≥256 mg/L. The MICs of cefoxitin, teicoplanin, vancomycin, gentamicin, enrofloxacin and d-cycloserine were unaltered in the uppP mutant relative to the wild-type, as were susceptibilities to other stress agents (glycine, lysozyme, NaCl, SDS, low and high pH, oxidative stress and ethanol).

Conclusions: The results demonstrate that low-level bacitracin resistance in E. faecalis is mediated by a BacA-type UppP.

Keywords: antimicrobials; cell wall inhibitors; gene expression.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Artificial Gene Fusion
  • Bacitracin / pharmacology*
  • Drug Resistance, Bacterial*
  • Enterococcus faecalis / drug effects
  • Enterococcus faecalis / enzymology*
  • Gene Expression Profiling
  • Gene Knockout Techniques
  • Genes, Reporter
  • Microbial Sensitivity Tests
  • Pyrophosphatases / genetics
  • Pyrophosphatases / metabolism*

Substances

  • Anti-Bacterial Agents
  • Bacitracin
  • Pyrophosphatases
  • undecaprenyl pyrophosphate phosphatase